Embedding Strategy into Portfolio Governance

In this opening keynote, Katherine Olig, VP of Program Management at Boston Scientific, explores how leading medtech organizations are embedding corporate strategy directly into portfolio governance frameworks. Drawing on her extensive experience driving program management excellence at one of the world's largest medical device companies, Katherine will share practical approaches for ensuring that every portfolio decision reinforces strategic intent.

Attendees will learn how Boston Scientific has evolved its governance model to create tighter alignment between strategic objectives and project selection, prioritization, and resource allocation. The session will address common pitfalls that cause strategy-governance disconnect and provide a roadmap for building governance structures that are both rigorous and adaptive.

Whether you are establishing portfolio governance for the first time or refining an existing framework, this keynote will equip you with actionable insights to make your governance processes a true engine of strategic execution.